The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy
Open accessAbstract
Background— Vasodilatory therapy of Raynaud’s phenomenon represents a difficult clinical problem because treatment often remains inefficient and may be not tolerated because of side effects. Methods and Results— To investigate the effects of sildenafil on symptoms and capillary perfusion in patients with Raynaud’s phenomenon, we performed a double-blinded, placebo-controlled, fixed-dose, crossover study in 16 patients with symptomatic secondary Raynaud’s phenomenon resistant to vasodilatory therapy. Patients were treated with 50 mg sildenafil or placebo twice daily for 4 weeks. Symptoms were assessed by diary cards including a 10-point Raynaud’s Condition Score. Capillary flow velocity was measured in digital nailfold capillaries by means of a laser Doppler anemometer. While taking sildenafil, the mean frequency of Raynaud attacks was significantly lower (35±14 versus 52±18, P =0.0064), the cumulative attack duration was significantly shorter (581±133 versus 1046±245 minutes, P =0.0038), and the mean Raynaud’s Condition Score was significantly lower (2.2±0.4 versus 3.0±0.5, P =0.0386). Capillary blood flow velocity increased in each individual patient, and the mean capillary flow velocity of all patients more than quadrupled after treatment with sildenafil (0.53±0.09 versus 0.13±0.02 mm/s, P =0.0004). Two patients reported side effects leading to discontinuation of the study drug. Conclusions— Sildenafil is an effective and well-tolerated treatment in patients with Raynaud’s phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Lue, T. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422407 · Cited by 1,252
Greenberg, M. S. (2016) · Thieme eBooks · doi:10.1055/b-006-149702 · Cited by 1,170
Principles and Practice of Laser-Doppler Anemometry
Durst, F., Melling, A., Whitelaw, J. H., & Wang, C. P. (1977) · Journal of Applied Mechanics · doi:10.1115/1.3424128 · Cited by 1,015
Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260203 · Cited by 1,006
Oral sildenafil in the treatment of erectile dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., Wicker, P. A., & Sildenafil Study Group (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80386-x · Cited by 502
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Ghofrani, H. A., Wiedemann, R., Rose, F., Olschewski, H., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00008 · Cited by 496
Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension
Zhao, L., Mason, N. A., Morrell, N. W., Kojonazarov, B., Sadykov, A., Maripov, A., Mirrakhimov, M. M., Aldashev, A., & Wilkins, M. R. (2001) · Circulation · doi:10.1161/hc2901.093117 · Cited by 488
Block, J. A., & Sequeira, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05118-7 · Cited by 422
Wigley, F. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013013 · Cited by 394
Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
Wilkens, H., Guth, A., König, J., Forestier, N., Cremers, B., Hennen, B., Böhm, M., & Sybrecht, G. W. (2001) · Circulation · doi:10.1161/hc3601.096826 · Cited by 392
Self-citationLaser Doppler measurements of blood flow in capillary tubes and retinal arteries.
Riva, C. E., Ross, B., & Benedek, G. B. (1972) · PubMed · Cited by 362
Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy
Maricq, H. R., & Carwile LeRoy, E. (1973) · Arthritis & Rheumatism · doi:10.1002/art.1780160506 · Cited by 339
Merkel, P. A., Herlyn, K., Martin, R. W., Anderson, J. J., Mayes, M. D., Bell, P., Korn, J. H., Simms, R. W., Csuka, M. E., Medsger, T. A., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10486 · Cited by 336
(2013) · Encyclopedia of Pain · doi:10.1007/978-3-642-28753-4_201135 · Cited by 326
Benenson, W., Harris, J. W., Horst Stöcker, B., & Lutz, H. (2002) · doi:10.1007/0-387-21632-4 · Cited by 311
Ghofrani, H. A., Reichenberger, F., Kohstall, M. G., Mrosek, E. H., Seeger, T., Olschewski, H., Seeger, W., & Grimminger, F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-3-200408030-00005 · Cited by 309
Katz, S. D., Balidemaj, K., Homma, S., Wu, H., Wang, J., & Maybaum, S. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00790-7 · Cited by 300
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
Thompson, A. E., Shea, B., Welch, V., Fenlon, D., & Pope, J. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1841::aid-art322>3.0.co;2-8 · Cited by 290
Hemodynamic Effects of Sildenafil in Men with Severe Coronary Artery Disease
Herrmann, H. C., Chang, G., Klugherz, B. D., & Mahoney, P. D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422201 · Cited by 287
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia
Halcox, J. P. J., Nour, K. R. A., Zalos, G., Mincemoyer, R., Waclawiw, M. A., Rivera, C. E., Willie, G., Ellahham, S., & Quyyumi, A. A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02139-3 · Cited by 274
Thomas, G. D., & Victor, R. G. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.817bv.x · Cited by 249
Basic Statistics for the Behavioral Sciences
Zelus, P. R., Hopkins, K. D., Glass, G. V., & Hopkins, B. R. (1987) · Teaching Sociology · doi:10.2307/1318009 · Cited by 243
Desouza, C., Parulkar, A., Lumpkin, D., Akers, D., & Fonseca, V. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1336 · Cited by 204
HEMODYNAMIC EFFECTS OF SILDENAFIL IN MEN WITH SEVERE CORONARY ARTERY DISEASE
Errmann, C. H., Hang, G. E. C., Lugherz, D. K., & Ahoney, P. A. D. M. (2000) · Cited by 194
A microscope-television system for studying flow velocity in human skin capillaries
Fagrell, B., Fronek, A., & Intaglietta, M. (1977) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1977.233.2.h318 · Cited by 185
Capillaroscopy and the measurement of capillary pressure
Shore, A. C. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00278.x · Cited by 164
Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique
Bollinger, A., Butti, P., Barras, J., Trachsler, H., & Siegenthaler, W. E. (1974) · Microvascular Research · doi:10.1016/0026-2862(74)90037-5 · Cited by 164
Kloner, R. A., & Zusman, R. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00114-9 · Cited by 108
Patterns of Diffusion through Skin Capillaries in Patients with Long-Term Diabetes
Bollinger, A., Frey, J., Jäger, K. A., Furrer, J., Seglias, J., & Siegenthaler, W. E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211183072103 · Cited by 107
Relative hematocrit in human skin capillaries and its relation to capillary blood flow velocity
Fagrell, B., Intaglietta, M., & Östergren, J. (1980) · Microvascular Research · doi:10.1016/0026-2862(80)90033-3 · Cited by 93
Fagrell, B. (1973) · PubMed · Cited by 77
Modulation of Human Platelet Aggregation by the Phosphodiesterase Type 5 Inhibitor Sildenafil
Berkels, R., Klotz, T., Sticht, G., Englemann, U., & Klaus, W. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200104000-00008 · Cited by 66
Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold
Bollinger, A., Jäger, K. A., Roten, A., Timeus, C., & Mahler, F. (1979) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00584215 · Cited by 61
Cremers, B., Scheler, M., Maack, C., Wendler, O., Schäfers, H., Südkamp, M., & Böhm, M. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200305000-00010 · Cited by 43
The dynamics of skin microcirculation as a tool for the study of systemic diseases.
Fagrell, B., & Intaglietta, M. (1977) · PubMed · Cited by 23
Fagrell, B., Rosén, L., & Eriksson, S. (2007) · International Journal of Microcirculation · doi:10.1159/000105065 · Cited by 20
Cited by
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
Metadata
- Authors
- Fries, R., Shariat, K., von Wilmowsky, H., & Böhm, M.
- Venue
- Circulation
- Published
- 2005-11-08
- Volume
- 112
- Issue
- 19
- Pages
- 2980-2985
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2164474017
- Cited by
- 337
- References
- 39
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.